Latest news
FDA Grants RMAT Designation to Sasineprocel for Parkinson Disease - NeurologyLiveNeurologyLive · Tue, 04 Aug 2026 22:35:24 GMTAspen Neuroscience Receives RMAT Designation for Parkinson's Therapy - SynBioBetaSynBioBeta · Tue, 04 Aug 2026 00:00:00 GMTClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel - ACCESS NewswireACCESS Newswire · Fri, 31 Jul 2026 20:07:34 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT